Bill · S.Res. 285· Senate(119-SRES-285)
A resolution designating July 16, 2025, as "Glioblastoma Awareness Day".
- Introduced
- 6/17/2025
- Last activity
- 6/17/2025 — Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S3442; text: CR S3441)
- Sponsored by
- Lindsey Graham
- Cosponsors
- - 2 - 7
- Introduced
- Officially Recorded
- Adopted by the Senate
A Senate resolution is the Senate speaking for itself: stating a position, honouring someone, or setting its own rules. Adopting it is the whole process. Once the Senate agrees to it, it is officially the Senate's word; it is not a law, so the House and the President have no part in it.
What this bill would do
This resolution designates July 16, 2025, as "Glioblastoma Awareness Day." The measure aims to increase public awareness regarding the urgent medical needs and treatment opportunities for glioblastoma patients. It honors those living with or who have died from this aggressive brain tumor. Additionally, the resolution supports the development of better treatments to improve quality of life and prognosis. It also urges a collaborative research approach and encourages continued investments in research and treatments.
Yes
Does this put more money into scientific research?+3
The resolution encourages continued investments in glioblastoma research and treatments.
Does this put more money into medical research?+3
The resolution encourages continued investments in glioblastoma research and treatments.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased Awareness and Support: The resolution encourages increased public awareness of glioblastoma and expresses support for those battling the disease, as well as their families, friends, and caregivers. (Resolution Section 2, 3, and 6)
-
Improved Treatment Outcomes: The measure supports efforts to develop better treatments intended to improve the quality of life and long-term prognosis for those diagnosed. (Resolution Section 4)
-
Advancement of Research: The resolution urges a collaborative approach to research among governmental, private, and nonprofit organizations and encourages continued investments in research and treatments, including through the Glioblastoma Therapeutics Network. (Resolution Section 7 and 8)
-
Recognition of Diagnostic Needs: The resolution recognizes the importance of molecular biomarker testing for the diagnosis and treatment of the disease. (Resolution Section 5)
Potential Negative Impacts for People
- No negative impacts or burdens are identified within the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Education And Technology
- Increases Scientific Research Funding+3
- Healthcare
- Increases Research Funding+3
- 6/17/2025
- Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.
- Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S3442; text: CR S3441)
- 9 Cosponsors added.
- Introduced in Senate
2 bills Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
John BarrassoRepublican · Wyoming
Christopher CoonsDemocrat · Delaware
Ruben GallegoDemocrat · Arizona
Mark KellyDemocrat · Arizona
Edward MarkeyDemocrat · Massachusetts
Tim ScottRepublican · South Carolina
Chris Van HollenDemocrat · Maryland
Raphael WarnockDemocrat · Georgia
Elizabeth WarrenDemocrat · Massachusetts